Table 3.
Intervention Group (n = 633) | Control Group (n = 553) | P value | |
---|---|---|---|
● Baseline Cost (previous 6 months, except*) | |||
Prescribed medication (*previous month) | 35.46 (1.86) | 33.55 (1.63) | 0.447 |
Primary care physician visit | 13.36 (1.23) | 16.57 (1.25) | 0.069 |
Specialist physician visit | 6.09 (1.03) | 9.27 (1.37) | 0.062 |
Emergency department | 7.33 (1.99) | 6.42 (1.82) | 0.739 |
Hospital admissions | 46.06 (31.95) | 91.28 (29.52) | 0.300 |
Total baseline cost | 72.85 (32.06) | 124.00 (30.06) | 0.447 |
● Medication and healthcare resources cost (sum of 6 months follow-up) | |||
Prescribed medication | 228.35 (11.98) | 209.52 (10.22) | 0.239 |
Primary care physician visit | 19.99 (2.23) | 23.51 (2.39) | 0.283 |
Specialist physicians visit | 6.50 (1.97) | 6.57 (1.40) | 0.978 |
Emergency department | 6.69 (1.93) | 12.01 (2.84) | 0.114 |
Hospital admissions | 42.07 (17.96) | 64.85 (21.02) | 0.407 |
Total cost in six months follow-up unadjusted | 321.80 (21.24) | 323.79 (24.07) | 0.239 |
● Intervention cost (6 months follow-up) | |||
Time of providing service | 24.92 (0.43) | – | |
Initial investment in pharmacy | 0.57 | – | |
Annual maintenance of service | 1.04 | – | |
Initial training of pharmacist | 0.38 | – | |
Visits of practice change facilitator to pharmacy | 0.42 | – | |
Total intervention cost | 27.33 (0.43) | – |
Notes: *It should be noted that the cost of prescribed medication only corresponds to one month in the baseline, while at the end of the study the sum of cost of six months were included. Statistical tests: t-test.